Not only have disease outbreaks decreased, but health and hygiene practices among residents have leapt forward meaning that many more can avoid succumbing to common diseases".
The mean duration of outbreaks decreased to 2.94 and 1.98 days in the group that took 1 capsule and 2 capsules, respectively (P = 0.058).
The median duration of outbreaks decreased from 7.00 to 5.00 days, in the pre-treatment and no-treatment control groups, respectively, to 2.00 days in the treatment group (Table 2).
In 75%% of the participants, the duration of outbreaks decreased to less than 5 days compared to 10.5 and 11 days in the no-treatment and pre-treatment groups, respectively (Fig. 1).
The mean duration of outbreaks decreased from 8.77 to 6.70 days, in the pre-treatment and no-treatment control groups, respectively, to 2.87 days in the treatment group (P < 0.001 for both groups) (Table 2).
While the total number of outbreaks decreased by half, those in the western states tripled.
Of all isolates sent to reference laboratory, the proportion of isolates from persistent outbreaks decreased from 47%to13%3%.
In the Northeast region, outbreaks decreased from 218181%) of 26 outbreaks in the United States in 1985 to 92020%) of 44 outbreaks in 1999.
If continuous prophylaxis was given for 8 weeks, the infection attack rate decreased to 0.05 (RR 0.23), and the percentage of large outbreaks decreased to 0.03 (RR 0.09).
The reporting timeliness gap for avian flu and H1N1 outbreaks decreased significantly after 2003, during a time when newly emerging infectious diseases such as SARS appeared.
